Literature DB >> 15253109

Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells.

Keisuke Ishizawa1, Masanori Yoshizumi, Koichiro Tsuchiya, Hitoshi Houchi, Kazuo Minakuchi, Yuki Izawa, Yasuhisa Kanematsu, Shoji Kagami, Masao Hirose, Toshiaki Tamaki.   

Abstract

We previously found that human chymase selectively cleaves big endothelin-1 (ET-1) at the Tyr31-Gly32 bond and produces 31-amino acid endothelins, ET-1 (1-31), without any further degradation products. In this study, we investigated the effect of ET-1 (1-31) on the migration of cultured rat mesangial cells (RMCs) and on cells of the human monocytic cell line, THP-1. In addition, we examined the interaction between RMCs and THP-1 cells using conditioned media from ET-1 (1-31)-stimulated RMCs. ET-1 (1-31) caused an increase in RMC migration in a concentration-dependent manner, and the degree of increase was similar to those by ET-1 and angiotensin II (All). The ET-1 (1-31)-induced increase in RMC migration was inhibited by BQ123, an endothelin ETA receptor antagonist, but not by BQ788, an endothelin ETB receptor antagonist. ET-1 (1-31) alone did not cause significant migration of THP-1 cells. However, significant recruitment of THP-1 cells was observed with conditioned media taken from ET-1 (1-31)-stimulated RMCs. The conditioned media-induced migration of THP-1 cells was inhibited by BQ123, but not by BQ788. Western blotting analysis of the lysate of RMCs revealed that the expression of monocyte chemoattractant protein-1 (MCP-1) protein in RMCs was increased by treatment with ET-1 (1-31). The addition of neutralizing antibody for MCP-1 to the medium inhibited the migration of THP-1 cells induced by conditioned media from ET-1 (1-31)-stimulated RMCs. These findings suggest that ET-1 (1-31) play a role in glomerulonephritis (GN) via dual effects that directly cause the migration of mesangial cells (MCs) and may be responsible for the recruitment of mononuclear cells mediated through the activation of MCs. Since human chymase has been reported to be involved in glomerular disease, ET-1 (1-31) may be among the mediators.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253109     DOI: 10.1291/hypres.27.433

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins.

Authors:  Ashok Chauhan; Sven Hahn; Suzanne Gartner; Carlos A Pardo; Senthil Kumar Netesan; Justin McArthur; Avindra Nath
Journal:  FASEB J       Date:  2006-12-28       Impact factor: 5.191

2.  Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.

Authors:  Takumi Sakurada; Keisuke Ishizawa; Masaki Imanishi; Yuki Izawa-Ishizawa; Shoko Fujii; Erika Tominaga; Teppei Tsuneishi; Yuya Horinouchi; Yoshitaka Kihira; Yasumasa Ikeda; Shuhei Tomita; Ken-ichi Aihara; Kazuo Minakuchi; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-14       Impact factor: 3.000

Review 3.  Inflammation and hypertension: new understandings and potential therapeutic targets.

Authors:  Carmen De Miguel; Nathan P Rudemiller; Justine M Abais; David L Mattson
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

4.  Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.

Authors:  Mohamed A Saleh; Erika I Boesen; Jennifer S Pollock; Virginia J Savin; David M Pollock
Journal:  Hypertension       Date:  2010-09-07       Impact factor: 10.190

5.  Exhaled nitric oxide from the central airway and alveoli in OSAHS patients: the potential correlations and clinical implications.

Authors:  Jie Liu; Zheng Li; Zilong Liu; Fen Zhu; Wenjing Li; Hong Jiang; Xiaodan Wu; Yuanlin Song; Shanqun Li; Chunxue Bai
Journal:  Sleep Breath       Date:  2015-06-18       Impact factor: 2.816

Review 6.  Endothelin-1 and the kidney--beyond BP.

Authors:  Neeraj Dhaun; David J Webb; David C Kluth
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

7.  Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1.

Authors:  Amy M Sutcliffe; Deborah L Clarke; Dawn A Bradbury; Lisa M Corbett; Jamie A Patel; Alan J Knox
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.